InfuSystem Holdings Past Earnings Performance
Past criteria checks 4/6
InfuSystem Holdings's earnings have been declining at an average annual rate of -39.3%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been growing at an average rate of 9.7% per year. InfuSystem Holdings's return on equity is 2.7%, and it has net margins of 1.1%.
Key information
-39.3%
Earnings growth rate
-39.7%
EPS growth rate
| Healthcare Industry Growth | 8.5% |
| Revenue growth rate | 9.7% |
| Return on equity | 2.7% |
| Net Margin | 1.1% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Revenue & Expenses Breakdown
How InfuSystem Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 133 | 1 | 62 | 0 |
| 30 Jun 24 | 129 | 0 | 61 | 0 |
| 31 Mar 24 | 127 | 0 | 60 | 0 |
| 31 Dec 23 | 126 | 1 | 58 | 0 |
| 30 Sep 23 | 123 | 1 | 55 | 0 |
| 30 Jun 23 | 118 | 1 | 56 | 0 |
| 31 Mar 23 | 114 | 0 | 56 | 0 |
| 31 Dec 22 | 110 | 0 | 56 | 0 |
| 30 Sep 22 | 108 | 0 | 56 | 0 |
| 30 Jun 22 | 107 | -1 | 56 | 0 |
| 31 Mar 22 | 104 | 0 | 55 | 0 |
| 31 Dec 21 | 102 | 1 | 51 | 0 |
| 30 Sep 21 | 100 | 12 | 53 | 0 |
| 30 Jun 21 | 99 | 15 | 49 | 0 |
| 31 Mar 21 | 100 | 18 | 46 | 0 |
| 31 Dec 20 | 97 | 17 | 45 | 0 |
| 30 Sep 20 | 94 | 7 | 43 | 0 |
| 30 Jun 20 | 90 | 6 | 41 | 0 |
| 31 Mar 20 | 84 | 2 | 40 | 0 |
| 31 Dec 19 | 81 | 1 | 39 | 0 |
| 30 Sep 19 | 77 | 0 | 36 | 0 |
| 30 Jun 19 | 72 | -1 | 36 | 0 |
| 31 Mar 19 | 69 | -2 | 35 | 0 |
| 31 Dec 18 | 67 | -1 | 34 | 0 |
| 30 Sep 18 | 67 | -19 | 34 | 0 |
| 30 Jun 18 | 67 | -18 | 33 | 0 |
| 31 Mar 18 | 66 | -19 | 33 | 0 |
| 31 Dec 17 | 65 | -21 | 34 | 0 |
| 30 Sep 17 | 63 | -3 | 34 | 0 |
| 30 Jun 17 | 63 | -3 | 33 | 0 |
| 31 Mar 17 | 64 | -2 | 33 | 0 |
| 31 Dec 16 | 65 | 0 | 33 | 0 |
| 30 Sep 16 | 67 | 2 | 33 | 0 |
| 30 Jun 16 | 68 | 3 | 34 | 0 |
| 31 Mar 16 | 66 | 3 | 34 | 0 |
| 31 Dec 15 | 65 | 3 | 34 | 0 |
| 30 Sep 15 | 63 | 2 | 33 | 0 |
| 30 Jun 15 | 62 | 2 | 32 | 0 |
| 31 Mar 15 | 61 | 2 | 31 | 0 |
| 31 Dec 14 | 61 | 3 | 30 | 0 |
| 30 Sep 14 | 61 | 3 | 29 | 0 |
| 30 Jun 14 | 59 | 3 | 28 | 0 |
| 31 Mar 14 | 58 | 2 | 28 | 0 |
| 31 Dec 13 | 56 | 2 | 28 | 0 |
Quality Earnings: INFU has high quality earnings.
Growing Profit Margin: INFU's current net profit margins (1.1%) are higher than last year (0.7%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: INFU's earnings have declined by 39.3% per year over the past 5 years.
Accelerating Growth: INFU's earnings growth over the past year (63.6%) exceeds its 5-year average (-39.3% per year).
Earnings vs Industry: INFU earnings growth over the past year (63.6%) exceeded the Healthcare industry 10.3%.
Return on Equity
High ROE: INFU's Return on Equity (2.7%) is considered low.